CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy.

ABSTRACT:

Background

CHMP4C is one of the charged multivesicular protein (CHMP), and is involved in the composition of the endosomal sorting complex required for transport III (ESCRT-III), facilitating the necessary separation of daughter cells. CHMP4C has been proposed to be involved in the progression of different carcinomas. However, the value of CHMP4C in prostate cancer has not yet been explored. Prostate cancer is the most frequently occurring malignancy among male and remains a leading cause of deaths in cancers. So far, clinical therapy of prostate cancer is more inclined to molecular classification and specific clinical treatment and research. Our study investigated the expression and clinical prognosis of CHMP4C and explored its potential regulatory mechanism in prostate cancer. Th

SUBMITTER: Zhang H 

PROVIDER: S-EPMC10301743 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature